0001493152-22-014000.txt : 20220516
0001493152-22-014000.hdr.sgml : 20220516
20220516175330
ACCESSION NUMBER: 0001493152-22-014000
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220516
DATE AS OF CHANGE: 20220516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Keeren
CENTRAL INDEX KEY: 0001898278
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41386
FILM NUMBER: 22931376
MAIL ADDRESS:
STREET 1: 55 PARK LANE
CITY: LONDON
STATE: X0
ZIP: W1K 1NA
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OKYO Pharma Ltd
CENTRAL INDEX KEY: 0001849296
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 55 PARK LANE
CITY: LONDON
STATE: X0
ZIP: W1K 1NA
BUSINESS PHONE: 44 (0) 207 495 2379
MAIL ADDRESS:
STREET 1: 55 PARK LANE
CITY: LONDON
STATE: X0
ZIP: W1K 1NA
3
1
ownership.xml
X0206
3
2022-05-16
0
0001849296
OKYO Pharma Ltd
OKYO
0001898278
Shah Keeren
C/O OKYO PHARMA LIMITED
MARTELLO COURT ADMIRAL PARK
ST. PETER PORT
Y7
GY1 3HB
GUERNSEY
0
1
0
0
Chief Financial Officer
Option (right to buy)
0.2025
2028-08-19
Ordinary Shares
300000
D
Option (right to buy)
0.0640
2031-08-31
Ordinary Shares
500000
D
Option (right to buy)
0.1045
2032-01-31
Ordinary Shares
150000
D
25% will vest each year on August 1, beginning on August 2, 2020.
25% will vest each year on August 1, beginning on August 31, 2021.
Vest in equal amounts over three years beginning on January 31, 2022.
/s/ Keeren Shah
2022-05-16